These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 26742513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 3. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J, Wang C, Chen N, Shu C, Guo X, He Y, Zhou Y.
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K, Herbepin VG, Touraine R, Almawi WY, Mahjoub T.
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
    Huang Z, Tang W, Liang Z, Chen Q, Li M, Li Y, Lao S, Pan H, Huang L, Huang M, Hu X, Zhao J.
    Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
    Li X, Liu Y, Zhang R, Tan J, Chen L, Liu Y.
    Med Sci Monit; 2015 Apr 11; 21():1051-6. PubMed ID: 25862335
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
    Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, Xu M.
    Vasa; 2020 Mar 11; 49(2):141-146. PubMed ID: 31920171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population.
    Cao Y, Chen W, Qian Y, Zeng Y, Liu W.
    Int J Neurosci; 2014 Dec 11; 124(12):874-81. PubMed ID: 24472072
    [Abstract] [Full Text] [Related]

  • 14. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke.
    Natesirinilkul R, Sasanakul W, Chuansumrit A, Kadegasem P, Visudtibhan A, Wongwerawattanakoon P, Sirachainan N.
    J Stroke Cerebrovasc Dis; 2014 Dec 11; 23(10):2566-2572. PubMed ID: 25284719
    [Abstract] [Full Text] [Related]

  • 15. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
    Gao WF, Guo YB, Bai Y, Ding XY, Yan YJ, Wu ZQ.
    Int Urol Nephrol; 2016 Sep 11; 48(9):1483-9. PubMed ID: 27272255
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
    Li YY.
    PLoS One; 2012 Sep 11; 7(4):e33511. PubMed ID: 22496752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
    Liang XN, Xie L, Cheng JW, Tan Z, Yao J, Liu Q, Su W, Qin X, Zhao JM.
    Thromb Res; 2013 Aug 11; 132(2):158-63. PubMed ID: 23856555
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH, Song GG.
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr 11; 175():8-14. PubMed ID: 24439532
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.